These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31102205)

  • 21. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
    Liu T; Liu D; Jin Y; Dong M
    Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-month stability study of a biosimilar of infliximab (Remsima
    Vieillard V; Astier A; Sauzay C; Paul M
    Ann Pharm Fr; 2017 Jan; 75(1):17-29. PubMed ID: 27659414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
    Pivot X; Bondarenko I; Nowecki Z; Dvorkin M; Trishkina E; Ahn JH; Vinnyk Y; Im SA; Sarosiek T; Chatterjee S; Wojtukiewicz MZ; Moiseyenko V; Shparyk Y; Bello M; Semiglazov V; Song S; Lim J
    J Clin Oncol; 2018 Apr; 36(10):968-974. PubMed ID: 29373094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects.
    Pivot X; Curtit E; Lee YJ; Golor G; Gauliard A; Shin D; Kim Y; Kim H; Fuhr R
    Clin Ther; 2016 Jul; 38(7):1665-1673.e3. PubMed ID: 27368117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.
    Lamanna WC; Heller K; Schneider D; Guerrasio R; Hampl V; Fritsch C; Schiestl M
    J Oncol Pharm Pract; 2019 Mar; 25(2):269-278. PubMed ID: 28950806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima
    Kim SJ; Kim KW; Shin YK; Kwon JW; Kang HY; Park YA; Shin JY; Kim SY; Han WY
    BioDrugs; 2019 Apr; 33(2):221-228. PubMed ID: 30747341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Milestones over the development of SB3, a trastuzumab biosimilar.
    Pivot X; Bondarenko I; Petit T; Curtit E
    Future Oncol; 2018 Nov; 14(27):2795-2803. PubMed ID: 29927335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis.
    Gao Y; Shelling AN; Porter D; Leung E; Wu Z
    Pharm Dev Technol; 2023; 28(3-4):288-298. PubMed ID: 36912800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the Stability of Sandoz Rituximab Biosimilar Rixathon
    Borišek R; Mischo A; Šmid I
    Drugs R D; 2022 Sep; 22(3):225-234. PubMed ID: 35933639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension.
    Lambert O; Bandilla D
    Drug Des Devel Ther; 2012; 6():235-44. PubMed ID: 23049244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biosimilars in oncology. Focus on SB3 studies.].
    Del Re M; Del Mastro L
    Recenti Prog Med; 2018 Nov; 109(11):531-539. PubMed ID: 30565572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the physicochemical and functional stability of diluted REMSIMA® upon extended storage--A study compliant with NHS (UK) guidance.
    Young BL; Khan MA; Chapman TJ; Parry R; Connolly MA; Watts AG
    Int J Pharm; 2015 Dec; 496(2):421-31. PubMed ID: 26456268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of infliximab solutions in different temperature and dilution conditions.
    Tokhadze N; Chennell P; Le Basle Y; Sautou V
    J Pharm Biomed Anal; 2018 Feb; 150():386-395. PubMed ID: 29287266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Gly
    Lymperis E; Kaloudi A; Kanellopoulos P; de Jong M; Krenning EP; Nock BA; Maina T
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30871262
    [No Abstract]   [Full Text] [Related]  

  • 35. Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags.
    Hendrickx TCJ; Balcaen KDH; Baert M; Haustraete J; Lambrecht BN
    Eur J Hosp Pharm; 2024 Jan; ():. PubMed ID: 38212080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidate.
    Arvinte T; Palais C; Poirier E; Cudd A; Rajendran S; Brokx S; Dowd J
    J Pharm Biomed Anal; 2019 Oct; 175():112742. PubMed ID: 31344647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3.
    Lüftner D; Lyman GH; Gonçalves J; Pivot X; Seo M
    Target Oncol; 2020 Aug; 15(4):467-475. PubMed ID: 32748046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization.
    Miranda-Hernández MP; López-Morales CA; Piña-Lara N; Perdomo-Abúndez FC; Pérez NO; Revilla-Beltri J; Molina-Pérez A; Estrada-Marín L; Flores-Ortiz LF; Ruiz-Argüelles A; Medina-Rivero E
    Biomed Res Int; 2015; 2015():874916. PubMed ID: 26682224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted.
    Lambert O; Bandilla D; Iyer R; Witchey-Lakshmanan L; Palepu N
    Drug Des Devel Ther; 2012; 6():61-70. PubMed ID: 22563237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations.
    Kolberg HC; Demetriou GS; Hanes V
    Oncol Ther; 2021 Jun; 9(1):225-238. PubMed ID: 33428085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.